Eli Lilly

Associate Vice President of Applied Intelligence for Discovery (AI4D) at Eli Lilly, responsible for the technical vision and execution of AI capabilities to transform drug discovery research. This role involves building and leading a multidisciplinary team, setting the technical roadmap for AI/ML platforms, guiding architecture decisions for end-to-end ML workflows, and driving adoption of MLOps practices. The goal is to create computationally driven discovery processes by building platforms where AI enables new workflows, moving beyond mere computational support.

This role focuses on developing and implementing a digital strategy for integrating AI, ML, and automation into quantitative pharmacology and pharmacometrics workflows within a healthcare setting. The goal is to accelerate drug development, position the organization as an industry leader in AI-enabled drug development, and ensure scientific rigor and regulatory compliance. The role involves evaluating emerging AI technologies, leading pilots, partnering with IT and data science teams, driving AI adoption through organizational change, and defining success metrics.